Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 18,156
- Companies
- 1,062
- Drugs tracked
- 3,385
Quick answer
NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
ABEMACICLIB , FULVESTRANT
Eli Lilly Co.
Breast cancer
1 trial -
ANASTROZOLE , PALBOCICLIB , TERSOLISIB, RIBOCICLIB , EXEMESTANE , FULVESTRANT , abemaciclib, TERSOLISIB, TERSOLISIB, TERSOLISIB, LETROZOLE , TERSOLISIB, to match Tersolisib (LY4064809), STX-478
Eli Lilly Co.
Neoplasm Metastasis, Breast Neoplasms
1 trial -
Abemaciclib
United Therapeutics Europe Ltd
Breast Cancer Female
1 trial -
Abemaciclib, Lasofoxifene, Fulvestrant
Pharma Mar S.A.
Locally advanced or metastatic breast cancer
1 trial -
FULVESTRANT , EXEMESTANE , ABEMACICLIB
Eli Lilly Co.
Breast Cancer
1 trial -
IBRANCE 75 mg film-coated tablets, GOSERELIN ACETATE, Placebo to match camizestrant, Placebo to match anastrozole, camizestrant, ABEMACICLIB, Placebo to match letrozole, IBRANCE 100 mg film-coated tablets, Arimidex® 1 mg Filmtabletten, IBRANCE 125 mg film-coated tablets, RIBOCICLIB, LETROZOLE, LEUPRORELIN ACETATE, ABEMACICLIB, Camizestrant, ABEMACICLIB
AstraZeneca AB
Estrogen Receptor-Positive, HER-2 negative Advanced Breast Cancer
1 trial -
LETROZOLE, Arimidex® 1 mg Filmtabletten, Camizestrant, ABEMACICLIB, GOSERELIN, TRIPTORELIN, LEUPRORELIN ACETATE, Nolvadex® 20 mg Filmtabletten, EXEMESTANE
AstraZeneca AB
ER+/HER2- Early Breast Cancer
1 trial -
LETROZOLE, IBRANCE 75 mg hard capsules, RIBOCICLIB, ABEMACICLIB, IBRANCE 100 mg hard capsules, ABEMACICLIB, IBRANCE 125 mg hard capsules, ABEMACICLIB
Pfizer Ireland Pharmaceuticals Unlimited Company
Advanced/Metastatic Breast Cancer
1 trial -
PREDNISOLONE , Verzenios 50 mg film-coated tablets, Placebo to match LY2835219 (Abemaciclib) Tablets, Placebo to match LY2835219 (Abemaciclib) Capsules, PREDNISONE , ABIRATERONE
Eli Lilly Co.
Prostate Cancer
1 trial -
Placebo to match abemaciclib, Verzenios 50 mg film-coated tablets, FULVESTRANT
Eli Lilly Co.
Breast Neoplasm, Neoplasm Metastasis
1 trial -
A study of niraparib in combination with abemaciclib for late line treatment of ovarian cancer: a single center, open label, single arm, phase Ib/II trial (NICHOL TRIAL)
Fondazione Telethon ETS
Ovarian cancer
1 trial -
ABEMACICLIB , RO7197597
Fondazione Telethon ETS
ER-positive, HER2-negative Early breast cancer
1 trial -
Abemaciclib
KAZIA THERAPEUTICS LTD
CDK Gene Mutation
1 trial -
Abemaciclib
China SXT Pharmaceuticals
Liver Metastases From Colorectal Cancer (mCRC)
1 trial -
Abemaciclib
Teva Pharma GmbH
Triple Negative Breast Neoplasms
1 trial -
Abemaciclib, Abemaciclib, Verzenios 50 mg film-coated tablets, TEMOZOLOMIDE
Eli Lilly Co.
Glioma
1 trial -
Abemaciclib, TEMOZOLOMIDE , Verzenios 50 mg film-coated tablets, IRINOTECAN
Eli Lilly Co.
Relapsed/Refractory Solid Tumors
1 trial -
Abemaciclib, dexamethasone, ixazomib, pomalidomide
Karyopharm Therapeutics
Relapsed Refractory Multiple Myeloma
1 trial -
ORSERDU 86 mg film-coated tablets, ABEMACICLIB, ABEMACICLIB, ORSERDU 345 mg film-coated tablets, ABEMACICLIB
Stemline Therapeutics B.V.
Brain Metastasis from Estrogen Receptor Positive, HER-2 Negative Breast Cancer
1 trial -
PALBOCICLIB, Zoladex 3,6 mg implante en jeringa precargada, AZD8421, PALBOCICLIB, AZD8421, PALBOCICLIB, PALBOCICLIB, RIBOCICLIB, Camizestrant, PALBOCICLIB, ABEMACICLIB, PALBOCICLIB, ABEMACICLIB, AZD8421, ABEMACICLIB
AstraZeneca AB
Patients with ER+ HER2- advanced breast cancer and patients with high-grade serious ovarian cancer (HGSOC)
1 trial -
Verzenios 50 mg film-coated tablets, TEMOZOLOMIDE , IRINOTECAN , Abemaciclib, Abemaciclib
Eli Lilly Co.
Ewings Sarcoma
1 trial -
Abemaciclib Plus Darolutamide in Prostate Cancer That Has Spread After Initial Treatment
Eli Lilly Co.
Prostatic Neoplasms
1 trial -
Study of Abemaciclib with Pembrolizumab in Patients with Stage IV Lung Cancer or Breast Cancer
Eli Lilly Co.
Lung Cancer or Breast Cancer
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources